← Human Trials & Peer-Reviewed Studies
Growth hormone, prolactin and cortisol response to exercise in patients with depression.
Plain-language guide to PMID 20149929 (2010): single-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 20149929
- Journal
- Journal of affective disorders
- Year
- 2010
- Study type
- Randomized Controlled Trial
- Authors
- Krogh J et al. (4 authors)
- DOI
- 10.1016/j.jad.2010.01.009
What This Study Did, in Plain Language
What Was Tested
Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.
This study investigated these hormones in response to acute exercise using an incremental bicycle test.
Who Took Part
By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.
A cross-sectional comparison of cortisol, growth hormone, and prolactin in depressed (n=137) and healthy (n=44) subjects during rest and in response to an incremental bicycle test.
How the Study Was Run
The design is described as randomized and single-blind.
Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Only one side, usually the participants, was kept unaware of whether Exogenous HGH, sermorelin & older GHRPs (why they're passed over) was given.
What Was Measured
This study investigated these hormones in response to acute exercise using an incremental bicycle test.
The subject headings attached to it are Cross-Sectional Studies, Denmark, Major Depressive Disorder, Exercise, Exercise Test, Human Growth Hormone and Hydrocortisone.
What This Means in Plain Language
The paper is a randomized and single-blind study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2010 (Journal of affective disorders), a journal based in Netherlands.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.